United States Antimony (UAMY) director receives RSU and 12,259-share option grant

Rhea-AI Filing Summary

United States Antimony Corp director Michael A. McManus Jr. reported equity awards under the company’s Amended & Restated 2023 Equity Incentive Plan. On January 15, 2026, he acquired 6,635 shares of common stock at $0 as part of a time-based restricted stock unit grant. These shares represent one-third of a larger 19,903-share RSU award, with the remaining portions scheduled to vest in equal tranches on January 15, 2027 and January 18, 2028, subject to his continued service.

He was also granted a stock option for 12,259 shares of common stock at an exercise price of $8.29 per share, vesting in three equal installments of 4,087 shares on January 15, 2027, January 18, 2028, and January 16, 2029, again contingent on continued service. Following these transactions, McManus beneficially owned 538,600 shares of common stock directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCMANUS MICHAEL A JR

(Last) (First) (Middle)

4438 W. LOVERS LANE, UNIT 100

(Street)

DALLAS TX 75209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITED STATES ANTIMONY CORP [ UAMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	01/15/2026(1)		A		6,635	A	$0	538,600	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option(2)	$8.29	01/15/2026		A		12,259(2)		(2)	(2)	Common Stock	12,259	(2)	0(2)	D

Explanation of Responses:

1. Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 6,635 shares of the 19,903 total number of shares of the RSU award will vest on January 15, 2026, and an additional one-third of the total number of shares will vest on January 15, 2027 and January 18, 2028, subject to the Reporting Person's continued service through each vesting date.

2. Represents shares of Common Stock underlying a time-based vesting stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 4,087 shares of the 12,259 total number of shares on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 16, 2029, subject to the Reporting Person's continued service through any vesting date.

	/s/ Michael McManus	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UAMY director Michael McManus report?

Director Michael A. McManus Jr. reported receiving 6,635 shares of UAMY common stock at $0 and a stock option for 12,259 shares on January 15, 2026, as equity compensation.

How many United States Antimony (UAMY) RSU shares were granted to the director?

The time-based RSU award covers 19,903 shares of common stock. One-third, or 6,635 shares, vested on January 15, 2026, with the remaining two-thirds scheduled to vest in equal tranches in 2027 and 2028, subject to continued service.

What are the terms of the UAMY stock option granted on January 15, 2026?

The director received a stock option for 12,259 shares of UAMY common stock with an exercise price of $8.29 per share. The option vests in three equal installments of 4,087 shares on January 15, 2027, January 18, 2028, and January 16, 2029, conditioned on continued service.

How many UAMY shares does the director beneficially own after this Form 4?

After the reported transactions, director Michael A. McManus Jr. beneficially owned 538,600 shares of United States Antimony common stock directly.

Was cash paid for the UAMY shares and options in this Form 4?

No cash was paid on grant; the 6,635 common shares and the 12,259-share stock option were reported with a price of $0 at the time of grant as part of equity compensation.

Under which plan were the UAMY RSUs and options granted?

Both the RSU award and the stock option were granted under United States Antimony’s Amended & Restated 2023 Equity Incentive Plan.